These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 1369312)
1. New pyrrolobenzodiazepine antibiotics, RK-1441A and B. I. Biological properties. Osada H; Ishinabe K; Yano T; Kajikawa K; Isono K Agric Biol Chem; 1990 Nov; 54(11):2875-81. PubMed ID: 1369312 [TBL] [Abstract][Full Text] [Related]
2. New pyrrolobenzodiazepine antibiotics, RK-1441A and B. II. Isolation and structure. Osada H; Uramoto M; Uzawa J; Kajikawa K; Isono K Agric Biol Chem; 1990 Nov; 54(11):2883-7. PubMed ID: 1368648 [TBL] [Abstract][Full Text] [Related]
3. Caboxamycin, a new antibiotic of the benzoxazole family produced by the deep-sea strain Streptomyces sp. NTK 937. Hohmann C; Schneider K; Bruntner C; Irran E; Nicholson G; Bull AT; Jones AL; Brown R; Stach JE; Goodfellow M; Beil W; Krämer M; Imhoff JF; Süssmuth RD; Fiedler HP J Antibiot (Tokyo); 2009 Feb; 62(2):99-104. PubMed ID: 19198633 [TBL] [Abstract][Full Text] [Related]
4. [Use of the method of phage induction for the isolation and purification of antitumor antibiotics]. Gauze GF; Terekhova LP; Kudinova MK; Rossolimo OK; Ukholina RS; Kovsharova IN; Nechaeva NP Antibiotiki; 1967 Mar; 12(3):179-83. PubMed ID: 4874765 [No Abstract] [Full Text] [Related]
6. Guadinomines, Type III secretion system inhibitors, produced by Streptomyces sp. K01-0509. I: taxonomy, fermentation, isolation and biological properties. Iwatsuki M; Uchida R; Yoshijima H; Ui H; Shiomi K; Matsumoto A; Takahashi Y; Abe A; Tomoda H; Omura S J Antibiot (Tokyo); 2008 Apr; 61(4):222-9. PubMed ID: 18503201 [TBL] [Abstract][Full Text] [Related]
7. Syntheses and biological activities (topoisomerase inhibition and antitumor and antimicrobial properties) of rebeccamycin analogues bearing modified sugar moieties and substituted on the imide nitrogen with a methyl group. Anizon F; Belin L; Moreau P; Sancelme M; Voldoire A; Prudhomme M; Ollier M; Sevère D; Riou JF; Bailly C; Fabbro D; Meyer T J Med Chem; 1997 Oct; 40(21):3456-65. PubMed ID: 9341921 [TBL] [Abstract][Full Text] [Related]
8. UCH9, a new antitumor antibiotic produced by Streptomyces: I. Producing organism, fermentation, isolation and biological activities. Ogawa H; Yamashita Y; Katahira R; Chiba S; Iwasaki T; Ashizawa T; Nakano H J Antibiot (Tokyo); 1998 Mar; 51(3):261-6. PubMed ID: 9589060 [TBL] [Abstract][Full Text] [Related]
10. Sensitivity and permeability of the anthramycin producing organism Streptomyces refuineus to anthramycin and structurally related antibiotics. Rokem JS; Hurley LH J Antibiot (Tokyo); 1981 Sep; 34(9):1171-4. PubMed ID: 6895748 [TBL] [Abstract][Full Text] [Related]
12. Novel antitumor antibiotics, saptomycins. I. Taxonomy of the producing organism, fermentation, HPLC analysis and biological activities. Abe N; Nakakita Y; Nakamura T; Enoki N; Uchida H; Munekata M J Antibiot (Tokyo); 1993 Oct; 46(10):1530-5. PubMed ID: 8244880 [TBL] [Abstract][Full Text] [Related]
13. U-43,120; a new antitumor antibiotic. I. Production, biological activity, microbiological assay and taxonomy of the producing microorganism. Hanka LJ; Dietz A J Antibiot (Tokyo); 1976 Jun; 29(6):611-7. PubMed ID: 950315 [TBL] [Abstract][Full Text] [Related]
14. Terpentecin and ECT4B, new family of topoisomerase II targeting antitumor antibiotics produced by Streptomyces: producing organism, fermentation and large scale purification. Kawada S; Yamashita Y; Ochiai K; Ando K; Iwasaki T; Takiguchi T; Nakano H J Antibiot (Tokyo); 1995 Mar; 48(3):211-6. PubMed ID: 7730154 [TBL] [Abstract][Full Text] [Related]
15. UK-2A, B, C and D, novel antifungal antibiotics from Streptomyces sp. 517-02. I. Fermentation, isolation, and biological properties. Ueki M; Abe K; Hanafi M; Shibata K; Tanaka T; Taniguchi M J Antibiot (Tokyo); 1996 Jul; 49(7):639-43. PubMed ID: 8784423 [TBL] [Abstract][Full Text] [Related]
16. Thrazarine, a new antitumor antibiotic. I. Taxonomy, fermentation, isolation and biological properties. Kameyama T; Takahashi A; Matsumoto H; Kurasawa S; Hamada M; Okami Y; Ishizuka M; Takeuchi T J Antibiot (Tokyo); 1988 Nov; 41(11):1561-7. PubMed ID: 3143704 [TBL] [Abstract][Full Text] [Related]
17. Production of new hybrid antibiotics, mederrhodins A and B, by a genetically engineered strain. Omura S; Ikeda H; Malpartida F; Kieser HM; Hopwood DA Antimicrob Agents Chemother; 1986 Jan; 29(1):13-9. PubMed ID: 3460518 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and antitumor activity of a new class of pyrazolo[4,3-e]pyrrolo[1,2-a][1,4]diazepinone analogues of pyrrolo[1,4][2,1-c]benzodiazepines. Baraldi PG; Leoni A; Cacciari B; Manfredini S; Simoni D; Bergomi M; Menta E; Spinelli S J Med Chem; 1994 Dec; 37(25):4329-37. PubMed ID: 7996544 [TBL] [Abstract][Full Text] [Related]
19. In vitro methods used in detection and quantitation of antitumor drugs produced by microbial fermentations. Hanka LJ; Martin DG; Neil GL Lloydia; 1978; 41(2):85-97. PubMed ID: 651563 [No Abstract] [Full Text] [Related]
20. Variation in the inhibition of restriction enzyme cleavage of lambda phage DNA produced by two covalent binding antitumor agents: anthramycin and mitomycin C. Kaplan DJ Biochem Biophys Res Commun; 1982 Dec; 109(3):639-48. PubMed ID: 6297483 [No Abstract] [Full Text] [Related] [Next] [New Search]